Celaid Therapeutics and Knowledge Palette executed a collaborative research contract. In this research, Knowledge Palette analyze frozen cord blood samples prepared by Celaid Therapeutics using the single-cell transcriptome technology of Knowledge Palette to clarify the characteristics of the cells in the cord blood samples. Through this research, we aim to realize more stable manufacturing and quality control of cord blood-derived cell therapy products.
About Knowledge Palette, Inc.
Knowledge Palette is a Japanese biotechnology company conducting phenotypic drug discovery, biomarkers identification, and improvement of regenerative medicine manufacturing based on our single cell transcriptome analysis technology (Quartz-Seq2), which was ranked No.1 for both accuracy scores and overall scores in an international benchmark project in 2020. We are collaborating with pharmaceutical companies and research institutes on acceleration of drug discovery as well as optimization of cell culturing for regenerative medicines.
Knowledge Palette, Inc.
Address：3-25-22 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan